Plasma cfDNA concentration was positively correlated with TF, although this varied across different tumor types; for instance, ctDNA-positive colorectal cancer samples possessed a higher median concentration (median 25.57 ng/mL plasma) compared to ctDNA-positive lung cancer samples (median 15.50 ng/mL; Fig 5B). This evidence concerns the gene TF and colorectal cancer.